Prime Medicine Inc.
PRME | NASDAQ
$3.19
+$0.07 (+2.24%)
At close: Sep 21, 2026, 4:00 PM ET
$3.22
+$0.03 (+0.94%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 4.63M | 2.98M | n/a | n/a | n/a | 5.21M |
Cost of Revenue | 7.32M | n/a | n/a | n/a | n/a | 2.98M |
Gross Profit | -2.69M | 2.98M | n/a | n/a | n/a | 2.23M |
Operating Income | -208.35M | -202.47M | -204.79M | -116.54M | -84.47M | -932K |
Interest Income | 4.15M | 3.52M | n/a | n/a | n/a | n/a |
Pretax Income | -201.14M | -195.88M | -198.41M | -122.77M | -165.85M | -1.54M |
Net Income | -201.14M | -195.88M | -198.13M | -121.82M | -165.37M | -3.41M |
Selling & General & Admin | 52.35M | 50.16M | 43.39M | 29.82M | 13.92M | 3.16M |
Research & Development | 160.64M | 155.29M | 147.91M | 86.73M | 70.55M | 2.98M |
Other Expenses | -7.32M | n/a | 13.5M | n/a | n/a | -2.98M |
Operating Expenses | 205.66M | 205.45M | 204.79M | 116.54M | 84.47M | 3.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 212.98M | 205.45M | 204.79M | 116.54M | 84.47M | 6.14M |
Income Tax Expense | n/a | n/a | -279K | -948K | -486K | 1.87M |
Shares Outstanding (Basic) | 148.76M | 118.6M | 90.97M | 97.21M | 95.73M | 95.73M |
Shares Outstanding (Diluted) | 148.76M | 118.6M | 90.97M | 97.21M | 95.73M | 95.73M |
EPS (Basic) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 |
EPS (Diluted) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 |
EBITDA | -195.76M | -189.75M | -186.64M | -120.55M | -165.29M | -889K |
EBIT | -201.14M | -195.88M | -191.29M | -122.77M | -165.85M | -932K |
Depreciation & Amortization | 5.38M | 6.13M | 4.65M | 2.22M | 568K | 43K |
Add to Watchlist
Select watchlists to add or remove PRME